Fractures and bone mineral density in adult women with 21-hydroxylase deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 12, 2007, Pages 4643-4649

  Falhammar, Henrik ^a   Filipsson, Helena ^b   Holmdahl, Gundela ^b   Janson, Per Olof ^b   Nordenskjöld, Agneta ^a   Hagenfeldt, Kerstin ^a   Thorén, Marja ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CARBOXY TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BONE ATROPHY; BONE METABOLISM; BONE MINERAL; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ELBOW FRACTURE; FEMALE; FEMUR NECK; FINGER FRACTURE; FOOT FRACTURE; FRACTURE; FRAGILITY FRACTURE; GENOTYPE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; RIB FRACTURE; SALT LOSING NEPHRITIS; SCAPHOID FRACTURE; STEROID 21 MONOOXYGENASE DEFICIENCY; TERTIARY HEALTH CARE; TOE; VERTEBRA FRACTURE; VIRILIZATION; WORLD HEALTH ORGANIZATION; WRIST FRACTURE;

EID: 36849055580     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0744     Document Type: Article

References (36)

1. White PC, Speiser PW 2000 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245-291
2. Merke DP, Bornstein SR 2005 Congenital adrenal hyperplasia. Lancet 365: 2125-2136
3. Falhammar H, Thorén M 2005 An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: connection or coincidence? J Endocrinol Invest 28:449-453
4. Shaker JL, Lukert BP 2005 Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 34:341-356
5. Filipsson H, Monson JP, Koltowska-Häggström M, Mattsson A, Johannsson G 2006 The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954-3961
6. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjold A, Hagenfeldt K, Thoren M 2007 Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:110-116
7. Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD 1995 Bone mineral density and body composition in congenital adrenal hyperplasia. J Clin Endocrinol Metab 80:2238-2243
8. Mora S, Saggion F, Russo G, Weber G, Bellini A, Prinster C, Chiumello G 1996 Bone density in young patients with congenital adrenal hyperplasia. Bone 18:337-340
9. Guo CY, Weetman AP, Eastell R 1996 Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 45:535-541
10. Gussinye M, Carrascosa A, Potau N, Enrubia M, Vincens-Calvet E, Ibanez L, Yeste D 1997 Bone mineral density in prepubertal and in adolescent and young adult patients with salt-wasting form of congenital adrenal hyperplasia. Pediatrics 100:671-674
11. Girgis R, Winter JS 1997 The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 82:3926-3929
12. Stikkelbroeck NM, Oyen WJ, van der Wilt GJ, Hermus AR, Otten BJ 2003 Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 88:1036-1042
13. Christiansen P, Molgaard C, Muller J 2004 Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 61:133-136
14. Speiser P, New M, Gertner J 1993 Increased bone mineral density in congenital adrenal hyperplasia (CAH). Pediatr Res 33:S81 (Abstract)
15. Arisaka O, Hoshi M, Kanazawa S, Numata M, Nakajima D, Kanno S, Negishi M, Nishikura K, Nitta A, Imataka M, Kuribayashi T, Kano K 2001 Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density. Metabolism 50:377-379
16. Jääskelainen J, Voutilainen R 1996 Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 45:707-713
17. Hagenfeldt K, Ritzen EM, Ringertz H, Helleday J, Carlstrom K 2000 Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur J Endocrinol 143:667-671
18. Paginini C, Radetti G, Livieri C, Braga V, Migliavacca D, Adami S 2000 Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm Res 54:164-168
19. King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ 2006 Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 91:865-869
20. Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S 2006 Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4453-4458
21. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK 2002 International variation in hip fracture probabilities: implication for risk assessment. J Bone Miner Res 17:1237-1244
22. Lajic S, Clauin S, Robins T, Vexiau P, Blanche H, Bellanne-Chantelot C, Wedell A 2002 Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab 87:2824-2829
23. Mazess RB, Barden HS, Bisek JP, Hansson J 1990 Dual energy x-ray absorptiometry for total body and regional bone mineral and soft tissue composition. Am J Clin Nutr 51:156-163
24. WHO 1994 Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: World Health Organization
25. Carter DR, Bouxsein ML, Marcus R 1992 New approaches for interpreting projected bone densitometry area. J Bone Miner Res 7:137-145
26. Katzman DK, Bachrach LK, Carter DK, Marcus R 1991 Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 73:1332-1339
27. Liddle GW 1961 Clinical pharmacology of anti-inflammatory steroids. Clin Pharmacol Ther 2:615-635
28. Miller WL 1991 The adrenal cortex. In: Rudolph AM, Hoffman JIE, eds. Rudolph's pediatrics. 19th ed. Norwalk, CT: Appleton & Lange; 1584-1613
29. Bang P, Eriksson U, Sara V, Wivall IL, Hall K 1991 Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determination in acid ethanol extracts by the use of truncated IGF-1 as radioligand. Acta Endocrinol (Copenh) 124:620-629
30. Hilding A, Hall K, Wivall-Helleryd IL, Sääf M, Melin AL, Thorén M 1999 Serum levels of insulin-like growth factor 1 in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84:2013-2019
31. Joint LWPES/ESPE CAH Working Group 2002 Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 87:4048-4053
32. Ogilvie CM, Crouch NS, Rumsby G, Creighton SM, Conway GS 2006 Congenital adrenal hyperplasia in adults: a review of medical, psychological and psychological issues. Clin Endocrinol (Oxf) 64:2-11
33. Canalis E, Bilezikian JP, Angeli A, Guistina A 2004 Perspectives on glucocorticoid-induced osteoporosis. Bone 34:593-598
34. Bang P, Degerblad M, Thorén M, Schwander J, Blum W, Hall K 1993 Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome. Acta Endocrinol 128:397-414
35. Zhou X, Loke KY, Pillai CC, How HK, Yap HK, Lee K-O 2001 IGFs and IGF-binding proteins in children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH. Eur J Endocrinol 144:237-243
36. Short RK, Nygren J, Bigelow ML, Nair KS 2004 Effect of short-term prednisone use on blood flow, muscle protein metabolism and function. J Clin Endocrinol Metab 89:6198-6207